Pharmaids Pharmaceuticals
PHARMAIDSPHARMACEUTICALSLTD NSE
Pharmaids Pharmaceuticals
HealthcareNSE: PHARMAIDSPHARMACEUTICALSLTD BSE: PHARMAID Pharmaceuticals
Key Fundamentals
MicrocapPharmaceuticalsHealthcareMarket Cap
₹106 Cr
Volatility
Moderate
P/E Ratio
-24.1
EBITDA
₹-13.20 Cr
Return on Equity
-24.31%
Debt to Equity
0.49
Book Value
₹13.51
EPS
₹0
52W High
₹66
52W Low
₹25.6
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company has reduced debt.
- Debtor days have improved from 56.1 to 44.9 days.
Weaknesses
3- Company has low interest coverage ratio.
- Promoter holding is low: 33.0%
- Company has a low return on equity of -19.4% over last 3 years.
Growth Rate
Revenue Growth
43.88% higher than
3Y
Net Income Growth
-14.07% higher than
3Y
Cash Flow Change
73.13% higher than
3Y
ROE
-0.94% higher than
3Y
ROCE
21.48% higher than
3Y
EBITDA Margin (Avg.)
-27.33% higher than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0.02 | 5.81 | 4.73 | 5.24 | 4.71 | 4.77 | 6.66 | 8.61 | 5.43 | 7.18 | 4.12 |
| Expenses | 1.61 | 1.02 | 2.45 | 11.39 | 8.14 | 7.65 | 7.6 | 8.67 | 12.03 | 13.93 | 7.94 | 7.52 | 4.87 |
| Operating Profit | -1.61 | -1.02 | -2.43 | -5.58 | -3.41 | -2.41 | -2.89 | -3.9 | -5.37 | -5.32 | -2.51 | -0.34 | -0.75 |
| OPM % | — | — | -12150% | -96.04% | -72.09% | -45.99% | -61.36% | -81.76% | -80.63% | -61.79% | -46.22% | -4.74% | -18.2% |
| Other Income | 0.41 | -0.26 | 0.76 | 0.12 | -0.07 | 0.08 | 0 | 0.13 | 0.04 | 3.03 | -0.32 | 0.01 | 4.25 |
| Interest | 0 | 0 | 0.02 | 0.77 | 0.26 | 0.33 | 0.48 | 1.01 | 1.2 | 0.93 | 0.72 | 0.65 | 0.6 |
| Depreciation | 0.01 | 0.01 | 0.04 | 0.63 | 0.57 | 0.61 | 0.64 | 0.62 | 0.61 | 0.47 | 0.48 | 0.48 | 0.49 |
| PBT | -1.21 | -1.29 | -1.73 | -6.86 | -4.31 | -3.27 | -4.01 | -5.4 | -7.14 | -3.69 | -4.03 | -1.46 | 2.41 |
| Tax % | 7.44% | -60.47% | -33.53% | -7.73% | -27.38% | -30.58% | -24.94% | -11.11% | -26.05% | -30.62% | -34.24% | -25.34% | 22.41% |
| Net Profit | -1.3 | -0.5 | -1.15 | -6.33 | -3.12 | -2.27 | -3.01 | -4.8 | -5.27 | -2.57 | -2.65 | -1.09 | 1.88 |
| EPS in Rs | -0.61 | -0.23 | -0.54 | -1.57 | -0.76 | -0.55 | -0.55 | -1.12 | -1.39 | -0.71 | -0.7 | -0.51 | 0.63 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 3.94 | 0 | 15.11 | 19.45 | 27.88 | 25.34 |
| Expenses | 3.81 | 9.89 | 27.46 | 32.2 | 41.39 | 34.26 |
| Operating Profit | 0.13 | -9.89 | -12.35 | -12.75 | -13.51 | -8.92 |
| OPM % | 3.3% | — | -81.73% | -65.55% | -48.46% | -35.2% |
| Other Income | 0.02 | 0 | 0.03 | 0.01 | 2.75 | 6.97 |
| Interest | 0 | 0 | 1.58 | 2.1 | 3.52 | 2.9 |
| Depreciation | 0.01 | 0.02 | 1.72 | 2.44 | 2.03 | 1.92 |
| PBT | 0.14 | -9.91 | -15.62 | -17.28 | -16.31 | -6.77 |
| Tax % | 0% | -23.71% | -24.2% | -21.88% | -29% | — |
| Net Profit | 0.15 | -7.56 | -11.85 | -13.51 | -11.57 | -4.43 |
| EPS in Rs | 0.15 | -3.52 | -2.26 | -3.06 | -3.32 | -1.29 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 10.27 | 21.44 | 35.27 | 35.27 | 35.27 |
| Reserves | -1.6 | 1.02 | 36.78 | 24.05 | 12.39 |
| Borrowings | 0 | 0 | 8.53 | 38.98 | 23.39 |
| Other Liabilities | 2.44 | 2.13 | 10.75 | 21.54 | 16.21 |
| Total Liabilities | 11.11 | 24.59 | 91.33 | 120 | 87.26 |
| Fixed Assets | 0.03 | 0.11 | 63.42 | 76.61 | 53.94 |
| CWIP | 0.45 | 2 | 7 | 4.53 | 6.1 |
| Investments | 0 | 3.31 | 0 | 0 | 0 |
| Other Assets | 10.63 | 19.17 | 20.91 | 38.7 | 27.22 |
| Total Assets | 11.11 | 24.59 | 91.33 | 120 | 87.26 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | -0.26 | -4.02 | -10.62 | -15.11 | -4.06 |
| Investing | 0.47 | -4.94 | -74.99 | -12.22 | 23.34 |
| Financing | 0 | 21.31 | 77.66 | 23.36 | -19.97 |
| Net Cash Flow | 0.21 | 12.35 | -7.95 | -3.98 | -0.69 |
| Free Cash Flow | -0.26 | -5.69 | -33.33 | -27.37 | 11.05 |
| CFO/OP | -200 | 41 | 86 | 118 | 30 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 124 | — | 64.74 | 58.74 | 44.9 |
| Inventory Days | 90.99 | 0 | 112 | 347 | 8.73 |
| Days Payable | 236 | — | 159 | 464 | 59.17 |
| Cash Conversion Cycle | -21.05 | — | 17.17 | -59.04 | -5.54 |
| Working Capital Days | -17.6 | — | -68.6 | -160 | -172 |
| ROCE % | — | -63.67% | -25.99% | -17.43% | -18.48% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Pharmaids Pharmaceuticals insights
58 extracted metrics + investor summaries across FY11–FY26.
Documents
2
Compliances-Reg.24(A)-Annual Secretarial Compliance
8 May - FY26 Annual Secretarial Compliance Report filed; no non-compliances or regulatory actions observed. 8 May - FY26 Annual Secretarial Compliance Report filed; no non-compliances or regulatory actions observed.
3
Announcement under Regulation 30 (LODR)-Newspaper Publication
24 Apr - Newspaper publication regarding the Special Window open for Re-Lodgement of transfer deeds. 24 Apr - Newspaper publication regarding the Special Window open for Re-Lodgement of transfer deeds.
4
Announcement under Regulation 30 (LODR)-Newspaper Publication
13h - Newspaper publication regarding the Special Window open for Re-Lodgement of transfer deeds. 13h - Newspaper publication regarding the Special Window open for Re-Lodgement of transfer deeds.
5
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7 Apr - Certificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations, 2018 for the quarter ended March 31, 2026. 7 Apr - Certificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations, 2018 for the quarter ended March 31, 2026.
Frequently Asked Questions about Pharmaids Pharmaceuticals
What does Pharmaids Pharmaceuticals Ltd do?
Incorporated in 1989, Pharmaids Pharmaceuticals Ltd operates in research, development, and manufacturing services.
It is undergoing a business transition and aims to build a CRDMO platform.[1]
Where is Pharmaids Pharmaceuticals Ltd (524572) listed?
Pharmaids Pharmaceuticals Ltd trades as PHARMAIDSPHARMACEUTICALSLTD on the NSE and under code PHARMAID on the BSE.
Which sector does Pharmaids Pharmaceuticals Ltd belong to?
Pharmaids Pharmaceuticals Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Pharmaids Pharmaceuticals Ltd?
Pharmaids Pharmaceuticals Ltd has a market capitalisation of ₹106.1 Cr, which places it in the Small Cap band.
What is the PE ratio of Pharmaids Pharmaceuticals Ltd?
Pharmaids Pharmaceuticals Ltd trades at a PE ratio of -24.10, on earnings per share of ₹0, against a book value of ₹13.51 per share.
What is the 52-week high and low of Pharmaids Pharmaceuticals Ltd?
Over the last 52 weeks Pharmaids Pharmaceuticals Ltd has traded between ₹25.6 and ₹66.
What is the Return on Equity (ROE) of Pharmaids Pharmaceuticals Ltd?
Pharmaids Pharmaceuticals Ltd reported a return on equity of -24.31%. Its debt-to-equity ratio is 0.49.
Company Information
Incorporated in 1989, Pharmaids Pharmaceuticals Ltd operates in research, development, and manufacturing services. It is undergoing a business transition and aims to build a CRDMO platform.[1]
Website pharmaids.com
Face Value ₹ 10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524572.md for Pharmaids Pharmaceuticals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.